blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1727789

EP1727789 - PHENYLETHANOLAMINE DERIVATIVES AS BETA-2 AGONISTS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  24.02.2012
Database last updated on 17.09.2024
Most recent event   Tooltip24.02.2012Application deemed to be withdrawnpublished on 28.03.2012  [2012/13]
Applicant(s)For:GB 
Pfizer Limited
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
For:AT  BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GR  HU  IE  IS  IT  LI  LT  LU  MC 
Brown, Alan Daniel
c/o Pfizer Global Research & Development, Ramsgate Road Sandwich
Kent CT13 9NJ / GB
[2006/49]
Inventor(s)01 / BROWN, Alan Daniel Pfizer Global Res.and Developm
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
02 / BUNNAGE, Mark, Edward Pfizer Global Res.and Devel.
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
03 / GLOSSOP, Paul, Alan Pfizer Global Res.and Develop.
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
04 / JAMES, Kim Pfizer Global Research and Development
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
05 / LANE, Charlotte, Alice, Luise Pfizer Global Res.
and Development Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
06 / LEWTHWAITE, Russell, Andrew Pfizer Global Res.and
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
07 / LUNN, Graham Pfizer Global Research and Develop.
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
08 / PRICE, David, Anthony Pfizer Global Res.and Devel.
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
 [2006/49]
Representative(s)Pringot, Thomas, et al
ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / FR
[N/P]
Former [2009/21]Pringot, Thomas, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Former [2009/20]Pringot, Thomas, et al
Pfizer Limited European Patent Department Ramsgate Road
Sandwich, Kent CT13 9NJ / FR
Former [2006/49]Pringot, Thomas
Pfizer European Patent Department 23/25 avenue du Docteur Lannelongue
F-75668 Paris Cedex 14 / FR
Application number, filing date05708731.410.03.2005
[2006/49]
WO2005IB00640
Priority number, dateEP2004029072517.03.2004         Original published format: EP 04290725
US20040591790P27.07.2004         Original published format: US 591790 P
GB2004002506412.11.2004         Original published format: GB 0425064
[2006/49]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005090287
Date:29.09.2005
Language:EN
[2005/39]
Type: A2 Application without search report 
No.:EP1727789
Date:06.12.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 29.09.2005 takes the place of the publication of the European patent application.
[2006/49]
Search report(s)International search report - published on:EP16.02.2006
ClassificationIPC:C07C237/20, C07D217/06, A61K31/165, A61K31/472
[2006/49]
CPC:
C07D217/06 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P11/16 (EP); A61P37/08 (EP);
A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/49]
Extension statesAL17.10.2006
BA17.10.2006
HR17.10.2006
LV17.10.2006
MK17.10.2006
YU17.10.2006
TitleGerman:PHENYLETHANOLAMINDERIVATE ALS BETA-2-AGONISTEN[2006/49]
English:PHENYLETHANOLAMINE DERIVATIVES AS BETA-2 AGONISTS[2006/49]
French:DÉRIVÉS BÉTA-2 AGONISTES DE LA PHÉNYLÉTHANOLAMINE[2006/49]
Entry into regional phase17.10.2006National basic fee paid 
17.10.2006Designation fee(s) paid 
17.10.2006Examination fee paid 
Examination procedure01.04.2005Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.08.2006Amendment by applicant (claims and/or description)
17.10.2006Examination requested  [2006/49]
19.02.2007Despatch of a communication from the examining division (Time limit: M06)
08.08.2007Reply to a communication from the examining division
01.04.2011Application deemed to be withdrawn, date of legal effect  [2012/13]
10.11.2011Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2012/13]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.02.2007
Fees paidRenewal fee
02.04.2007Renewal fee patent year 03
31.03.2008Renewal fee patent year 04
31.03.2009Renewal fee patent year 05
31.03.2010Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.201107   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]EP0006735  (BEECHAM GROUP PLC [GB]) [Y] 1,10,17-23 * example 11, first disclaimer *;
 [YD]EP0236624  (BEECHAM GROUP PLC [GB]) [YD] 1-26 * the whole document *;
 [Y]WO03042160  (THERAVANCE INC [US], et al) [Y] 1-26 * abstract *;
 [Y]WO0142193  (ADVANCED MEDICINE INC [US], et al) [Y] 1-26 * abstract *;
 [Y]WO03091204  (GLAXO GROUP LTD [GB], et al) [Y] 1-26 * abstract *;
 [Y]FR2562889  (GLAXO GROUP LTD [GB]) [Y] 1-26 * abstract *;
 [Y]FR2319334  (ALLEN & HANBURYS LTD [GB]) [Y] 1-26 * page 3; claim - *;
 [AP]EP1477167  (PFIZER LTD [GB]) [AP] 1-26 * examples, second disclaimer *
 [Y]  - APPERLEY G H ET AL, "Selectivity of Beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat", BRITISH JOURNAL OF PHARMACOLOGY, BASINGSTOKE, HANTS, GB, (1976), vol. 57, no. 2, ISSN 0007-1188, pages 235 - 246, XP000926140 [Y] 1-26 * page 237 *
 [Y]  - BONNERT R V ET AL, "DUAL D2-RECEPTOR AND BETA2-ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF AIRWAY DISEASES. 1. DISCOVERY AND BIOLOGICAL EVALUATION OF SOME 7-(2-AMINOETHYL)- 4-HYDROXYBENZOTHIAZOL-2(3H)-ONE ANALOGUES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1998), vol. 41, no. 25, ISSN 0022-2623, pages 4915 - 4917, XP000978960 [Y] 1-26 * page 4916 *

DOI:   http://dx.doi.org/10.1021/jm980421f
 [Y]  - CAMPILLO N ET AL, "NOVEL BRONCHODILATORS IN THE TREATMENT OF ASTHMA AND COPD", EXPERT OPINION ON THERAPEUTIC PATENTS, ASHLEY PUBLICATIONS, GB, (2002), vol. 1, no. 12, ISSN 1354-3776, pages 53 - 63, XP008002080 [Y] 1-26 * page 55 *

DOI:   http://dx.doi.org/10.1517/13543776.12.1.53
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.